Table 1.
Characteristics | Antihypertensive treatment (n = 314) | Control (n = 324) | P value |
---|---|---|---|
Age, mean (SD), year | 60.4 (10.1) | 59.8 (10.7) | 0.49 |
Men, n (%) | 227 (72.3) | 221 (68.2) | 0.26 |
Education, mean (SD), year | 7.9 (4.2) | 7.4 (4.0) | 0.13 |
Time from stroke onset to randomization, mean (SD), h | 14.5 (12.2) | 15.0 (12.3) | 0.6 |
Systolic blood pressure, mean (SD), mmHg | 167.7 (17.0) | 167.1 (16.3) | 0.64 |
Diastolic blood pressure, mean (SD), mmHg | 97.4 (9.8) | 98.9 (10.2) | 0.06 |
Body mass index, mean (SD), kg/m2 | 25.0 (3.1) | 24.8 (3.0) | 0.56 |
NIH stroke scale score, median (IQR) | 4.0 (3.0–7.0) | 4.0 (3.0–7.0) | 0.41 |
Disease history, n (%) | |||
Hypertension | 240 (76.4) | 254 (78.4) | 0.55 |
Hyperlipidemia | 19 (6.1) | 24 (7.4) | 0.49 |
Diabetes mellitus | 57 (18.2) | 52 (16.1) | 0.48 |
Coronary heart disease | 29 (9.2) | 39 (12.0) | 0.25 |
Current cigarette smoking, n (%) | 122 (38.9) | 119 (36.7) | 0.58 |
Current alcohol drinking, n (%) | 105 (33.4) | 115 (35.5) | 0.56 |
Ischemic stroke type, n (%) | |||
Thrombotic | 210 (66.9) | 213 (65.7) | 0.76 |
Embolic | 8 (2.6) | 15 (4.6) | 0.16 |
Lacunar | 98 (31.2) | 103 (31.8) | 0.87 |
Data are presented as number of patients with variable present (%), mean (SD), or median (interquartile range).